Clinical Trials Browser

Phase 1/2 × Terminated × N-Ac-CHAVC-NH2 × Clear all

NCT00225550 2007-08-06

A Study of the Safety and Effects of ADH-1 Given Daily to Subjects With Solid Tumors

Phase 1/2 Terminated

Neoplasms